About Blue Ocean Biomedical
Blue Ocean Biomedical specializes in the development of automated, load & go cell analysis systems for immune monitoring and related applications. Blue Ocean systems are optimized to address needs for specific moderate-to-high-demand applications where test results are desired in less time, with greater efficiency and at substantially lower costs. In April 2012, Blue Ocean Biomedical was acquired by Beckman Coulter. The valuation of Blue Ocean Biomedical was undisclosed. Other terms of the deal were not released.